Isomorphic Labs raises $2.1B for AI drug discovery

Isomorphic Labs, an AI drug discovery spinout from Google, said on Tuesday that it raised a $2.1 billion Series B.

Why it matters: It's another indication of investors' growing enthusiasm for the promise of AI in drug development.